Table 3.
Association of vaccine coverage rate with the demographic characteristics.
| Variables |
OCV1 |
OCV2 |
OPV1 |
OPV2 |
MR |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| AGE (years) | AOR (95% CI) | CR (%) | AOR (95% CI) | CR (%) | AOR (95% CI) | CR (%) | AOR (95% CI) | CR (%) | AOR (95% CI) | CR (%) |
| 0–5 | 1.07 (0.92, 1.54) | 95 | – | 92 | – | 75 | – | 88 | 1.12*(1.05, 1.27) | 41 |
| 6–15 | 1.11(0.89, 1.59) | 95 | – | – | – | – | – | – | 1.00 | 36 |
| 16+ | 1.00 | 93 | – | – | – | – | – | – | – | – |
| SEX | ||||||||||
| Male | 1.09* (1.00, 1.18) | 94 | 0.98 (0.83, 1.16) | 92 | 1.03 (0.93, 1.13) | 75 | 0.99 (0.87, 1.14) | 88 | 1.07*(1.00, 1.13) | 39 |
| Female (ref) | 1.00 | 93 | 1.00 | 92 | 1.00 | 75 | 1.00 | 88 | 1.00 | 38 |
| Duration of live in BD (months) | ||||||||||
| 0–3 | 1.04 (0.93, 1.59) | 93 | 0.99 (0.47, 1.19) | 91 | 0.41*(0.35, 0.48) | 71 | 0.98 (0.41, 1.63) | 87 | 0.66*(0.61, 0.71) | 35 |
| 4–6 | 1.13*(1.04, 1.60) | 97 | 1.03 (0.91, 1.47) | 94 | 0.92 (0.71, 1.18) | 86 | 1.10 (0.93, 2.37) | 93 | 0.95 (0.84, 1.06) | 46 |
| 7–12 (ref) | 1.00 | 91 | 1.00 | 91 | 1.00 | 87 | 1.00 | 88 | 1.00 | 47 |
AOR: adjusted odds ratio; CR: coverage rate; *Significant (5% level).